🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessBlue Cross Blue Shield — looking for input

Blue Cross Blue Shield — looking for input

KristenIndy Sat, Oct 4, 2025 at 7:06 AM 9 replies 1,167 viewsPage 1 of 2
This thread is more than 8 months old. Information may be outdated. Consider searching for more recent discussions.
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Oct 4, 2025 at 7:06 AM#1

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the talking.

The bit I cannot resolve on my own is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work.

Not looking for reassurance. Looking for the part I have got wrong.

50 20LondonLisa, mike_nyc, VendorMark and 47 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Oct 4, 2025 at 9:22 AM#2
KristenIndy said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…
KristenIndy said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Last edited: Oct 4, 2025 at 10:22 AM
49 19anna.melb_AU, mark_tokyo, hans_munich and 46 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Oct 4, 2025 at 11:38 AM#3
Dr.RaviCardio said:
KristenIndy said: ...regarding the discontinuation data for cost and coverage...

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $257/month (eating less)
  • Restaurants: SAVED $167/month (fewer meals out)
  • Alcohol: SAVED $117/month (stopped drinking)
  • Life insurance: Premium REDUCED by $47/month (lower BMI)
  • Copays: SAVED $67/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

48 18emma_london, tammy_FL, Dr.LipidDallas and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Oct 4, 2025 at 1:54 PM#4
KristenIndy said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Mine went the same way, slower.

Last edited: Oct 4, 2025 at 5:54 PM
47 17DoseLogDan, SleepFixSam, PurityPaulOR and 44 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Oct 5, 2025 at 3:28 AM#5

Clinical perspective, offered as context rather than as advice.

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

Last edited: Oct 5, 2025 at 8:28 AM
46 16claudia_zurich, nancy_portland, rick_sfbay and 43 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register